These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12621451)

  • 1. HIV-1 proprotein processing as a target for gene therapy.
    Cordelier P; Zern MA; Strayer DS
    Gene Ther; 2003 Mar; 10(6):467-77. PubMed ID: 12621451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional expression of alpha1-antitrypsin delivered by recombinant SV40 vectors protects lymphocytes against HIV.
    Cordelier P; Strayer DS
    Gene Ther; 2003 Dec; 10(26):2153-6. PubMed ID: 14625571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.
    Cordelier P; Strayer DS
    Virus Res; 2006 Jun; 118(1-2):87-97. PubMed ID: 16414141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
    BouHamdan M; Duan LX; Pomerantz RJ; Strayer DS
    Gene Ther; 1999 Apr; 6(4):660-6. PubMed ID: 10476226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H; von der Helm K; Nitschko H
    Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of alpha1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis.
    Cordelier P; Strayer DS
    Biochim Biophys Acta; 2003 Jul; 1638(3):197-207. PubMed ID: 12878320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.
    Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL
    Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
    Schroers R; Davis CM; Wagner HJ; Chen SY
    Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-activated interferon-alpha2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle.
    Cordelier P; Calarota SA; Strayer DS
    J Hematother Stem Cell Res; 2002 Oct; 11(5):817-28. PubMed ID: 12427288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of targeted gene transfer into human primary T lymphocytes and macrophages using high-titer recombinant HIV vectors.
    Miyake K; Miyake N; Shimada T
    J Biotechnol; 2007 May; 129(3):532-8. PubMed ID: 17307270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
    Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
    Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
    Chadwick DR; Lever AM
    Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mutant and wild-type gag proteins for gene therapy in HIV-1 infection.
    Miele G; Lever AM
    Gene Ther; 1996 Apr; 3(4):357-61. PubMed ID: 8732168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.